ALLIANCE A031803

Primary Category:

Treatment Protocols

Disease Category:

Bladder, Genitourinary

Status:

New, Open

Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

NCT#04164082